Insights

  • Home
  • Insights
  • Generative AI End-User License Agreements: What Users Need To Know

Share

Social Image Carl Kukkonen III Emily J Tait

Generative AI End-User License Agreements: What Users Need To Know

March 04, 2024 Reprint

In this article for The Licensing Journal, Carl Kukkonen III, Emily J. Tait, Undine Von Diemar, and Ka-On Li, detail how the end-user license agreements (EULAs) governing GenAI platforms need particular attention to mitigate legal risks.

Copyright © 2024 CCH Incorporated. All Rights Reserved. Reprinted from The Licensing Journal, January 2024, Volume 44, Number 1, pages 1-4, with permission from Wolters Kluwer, New York, NY.
You May Also Be Interested In

November 20, 2024 Newsletters

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 117

November 18, 2024 Alert

NIS 2 Directive: Transposition Period is Up for EU Member States

November 12, 2024 Alert

Inaugural Meeting for FDA's Digital Health Advisory Committee to Focus on GenAI-enabled Medical Devices

November 06, 2024 Alert

New York Imposes Stringent Cybersecurity and Cyber Incident Reporting Obligations on Hospitals

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.